欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/3902/001
药品名称Imipenem/Cilastatin Noridem 500mg/500mg Pulver zur Herstellung einer Infusionslösung
活性成分
    • Cilastatin 500.0 mg
    • Imipenem 500.0 mg
剂型Powder for solution for infusion
上市许可持有人Noridem Enterprises Ltd. Evagorou & Makariou, Mitsi Building 3, Suite 115 CY-1065 Nicosia
参考成员国 - 产品名称Germany (DE)
Imipenem/Cilastatin Noridem 500 mg/500 mg Pulver zur Herstellung einer Infusionslösung
互认成员国 - 产品名称
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
    • Hungary (HU)
      Imipenem/Cilastatin Noridem 500mg/500mg por oldatos infúzióhoz
    • Cyprus (CY)
      Imipenem/Cilastatin Noridem 500 mg/500 mg κόνις για διάλυμα προς έγχυση
    • Denmark (DK)
      Imipenem/Cilastatin Noridem
    • Czechia (CZ)
      Imipenem/Cilastatin Noridem
    • Netherlands (NL)
    • Romania (RO)
    • France (FR)
    • Slovakia (SK)
    • Spain (ES)
许可日期2014/08/19
最近更新日期2025/09/08
药物ATC编码
    • J01DH51 imipenem and cilastatin
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase